Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Case report: Adult-onset neuronal intranuclear inclusion disease with an amyotrophic lateral sclerosis phenotype

Fujita M, Ueno T, Miki Y, Arai A, Kurotaki H, Wakabayashi K, Tomiyama M.

Front Neurosci. 2022 Aug 10;16:960680. doi: 10.3389/fnins.2022.960680. eCollection 2022.

Should "on-demand" treatments for Parkinson's disease OFF episodes be used earlier?

Isaacson SH, Pagan FL, Lew MF, Pahwa R.

Clin Park Relat Disord. 2022 Aug 12;7:100161. doi: 10.1016/j.prdoa.2022.100161. eCollection 2022.

Exacerbation of Mania due to Metronidazole in a Bipolar Disorder Patient

AlShakori M, Arain SI, Thorakkattil SA, Abdulkader S.

Case Rep Psychiatry. 2022 Jun 2;2022:3748101. doi: 10.1155/2022/3748101. eCollection 2022.

Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches

Bhidayasiri R, Phuenpathom W, Tan AH, Leta V, Phumphid S, Chaudhuri KR, Pal PK.

Front Aging Neurosci. 2022 Aug 11;14:979826. doi: 10.3389/fnagi.2022.979826. eCollection 2022.

The relationship between Parkinson's disease and gastrointestinal diseases

Zeng J, Wang X, Pan F, Mao Z.

Front Aging Neurosci. 2022 Aug 10;14:955919. doi: 10.3389/fnagi.2022.955919. eCollection 2022.

Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis

Karpodini CC, Dinas PC, Angelopoulou E, Wyon MA, Haas AN, Bougiesi M, Papageorgiou SG, Koutedakis Y.

Front Neurol. 2022 Aug 9;13:875178. doi: 10.3389/fneur.2022.875178. eCollection 2022.

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease

Smith LJ, Lee CY, Menozzi E, Schapira AHV.

Front Neurol. 2022 Aug 12;13:971252. doi: 10.3389/fneur.2022.971252. eCollection 2022.

Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases

Jiang H, Zhang Y, Yue J, Shi Y, Xiao B, Xiao W, Luo Z.

Front Neurol. 2022 Aug 12;13:929290. doi: 10.3389/fneur.2022.929290. eCollection 2022.

Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future

Levin LA, Patrick C, Choudry NB, Sharif NA, Goldberg JL.

Front Neurol. 2022 Aug 12;13:964197. doi: 10.3389/fneur.2022.964197. eCollection 2022.

Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential

Mitra S, Muni M, Shawon NJ, Das R, Emran TB, Sharma R, Chandran D, Islam F, Hossain MJ, Safi SZ, Sweilam SH.

Oxid Med Cell Longev. 2022 Aug 18;2022:7252882. doi: 10.1155/2022/7252882. eCollection 2022.

Viruses, parkinsonism and Parkinson's disease: the past, present and future

Leta V, Urso D, Batzu L, Lau YH, Mathew D, Boura I, Raeder V, Falup-Pecurariu C, van Wamelen D, Ray Chaudhuri K.

J Neural Transm (Vienna). 2022 Sep;129(9):1119-1132. doi: 10.1007/s00702-022-02536-y. Epub 2022 Aug 29.

Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies

Bhawna, Kumar A, Bhatia M, Kapoor A, Kumar P, Kumar S.

Eur J Med Chem. 2022 Nov 15;242:114655. doi: 10.1016/j.ejmech.2022.114655. Epub 2022 Aug 18.

Type 2 diabetes mellitus augments Parkinson's disease risk or the other way around: Facts, challenges and future possibilities

Faizan M, Sarkar A, Singh MP.

Ageing Res Rev. 2022 Nov;81:101727. doi: 10.1016/j.arr.2022.101727. Epub 2022 Aug 28.

['Home away from house': an example of a reduplicative paramnesia]

Beg MI, Aben HP, van Asseldonk JTH, Tilanus JJD.

Tijdschr Psychiatr. 2022;64(7):470-473.

Inflammatory markers and depression in Parkinson's disease: a systematic review

Ramanzini LG, Camargo LFM, Silveira JOF, Bochi GV.

Neurol Sci. 2022 Dec;43(12):6707-6717. doi: 10.1007/s10072-022-06363-7. Epub 2022 Aug 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias